EQT Fund Management S.a r.l.

Position in AGMB — Agomab Therapeutics NV

CIK 1834239 LUXEMBOURG, N4

Position in AGMB

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$66,743,056

+$12,803,560 QoQ

Shares Held

5,141,992

0.0% QoQ

Ownership

10.4%

of shares outstanding

% of Portfolio

7.74%

of 13F equity value

Holder Rank

of 34 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EQT Fund Management S.a r.l. holds $351,848,291 across 4 Biotechnology names. AGMB ranks #4 (19.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PHVS	Pharvaris N.V.	3,424,609	$118,422,979
2	OCS	Oculis Holding AG	6,950,294	$96,400,577
3	EVMN	Evommune, Inc.	5,288,313	$70,281,679
4	AGMB	Agomab Therapeutics NV This page	5,141,992	$66,743,056

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$66,743,056	5,141,992	0.0%	Shares	Sole	2026-08-13
2026-03-31	$53,939,496	5,141,992	—	Shares	Sole	2026-05-14
No filing history on record for this holder in this stock.